
Made-in-Canada coronavirus vaccine to begin human clinical trials Tuesday
- Details
- Category: Tech & Science
- Published Tuesday, January 26, 2021
- CBC News

A made-in-Canada vaccine to protect against COVID-19 is to begin human clinical trials Tuesday in Toronto, says the biotechnology company that developed the vaccine.
Toronto-based Providence Therapeutics said three doses of its vaccine, called PTX-COVID19-B, will be given to 60 adult volunteers at a clinical trial site in Toronto in the first phase of the trial on Tuesday.